With integrated clinical, lab, and research teams onsite, BostonSight expands its capacity to support trials advancing the ...

Haller expands her leadership role of ophthalmologist-in-chief following the retirement of longtime executive Joseph P. Bilson.

Integrating IRIS technologies will allow Topcon to improve retinal disease diagnostics and referrals from primary care ...

The DRD Cure Accelerator, highlighted at the CCOI-Stanford Summit, is a global initiative advancing clinical research and ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

The annual Best Hospitals report from US News & World Report compares more than 4,500 hospitals across 15 specialties and 22 ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Annexon has completed enrollment in its phase 3 ARCHER II trial of vonaprument (formerly ANX007) for dry age-related macular ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

A recent study reveals that many Americans neglect eye care due to cost and urgency misconceptions, despite the significant ...

Discover groundbreaking findings on oral gildeuretinol's impact on Stargardt disease at the ASRS 43rd Annual Meeting in Long ...